A modified α-galactosyl ceramide for staining and stimulating natural killer T cells
- 6 March 2006
- journal article
- Published by Elsevier
- Vol. 312 (1-2) , 34-39
- https://doi.org/10.1016/j.jim.2006.02.009
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- α-Galactosylceramide therapy for autoimmune diseases: prospects and obstaclesNature Reviews Immunology, 2005
- Lysosomal Glycosphingolipid Recognition by NKT CellsScience, 2004
- CD1: Antigen Presentation and T Cell FunctionAnnual Review of Immunology, 2004
- Testing the NKT cell hypothesis of human IDDM pathogenesisJournal of Clinical Investigation, 2002
- CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cellsJournal of Immunological Methods, 2002
- Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer StainingThe Journal of Experimental Medicine, 2002
- TCRβ Chain Influences But Does Not Solely Control Autoreactivity of Vα14J281T CellsThe Journal of Immunology, 2001
- Human CD1d–glycolipid tetramers generated byin vitrooxidative refolding chromatographyProceedings of the National Academy of Sciences, 2001
- Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d TetramersThe Journal of Experimental Medicine, 2000
- Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing MiceJournal of Medicinal Chemistry, 1995